Pillars

 

Labs could be next on property block

Life science properties that incorporate some laboratories in one form or another could be the next property boom says Piers Scrimshaw-Wright, who has just joined Knight Frank as Life Science and Innovation partner. So has anything been sold in Europe so far?
December 2, 2021

Fresenius Helios expands in Colombia

Quironsalud, the Spanish arm of Fresenus Helios has expanded its Colombian business with the acquisition of Centro Oncológico de Antioquia and ophthalmology centre Clínica Clofán. In its nine month results Fresenius stated that Latin America were strong and "notably above expectations." We look at a booming market where Fresenius Helios spent the lion's share of its €770m on M&A deals in 2020 and 2019 alone.
November 25, 2021

French municipalities seek to privatise care homes

Municipality-owned French care homes are in crisis. Tired, old buildings, with low tariffs and now, following Covid, far lower occupancy rates are leading many to consider the unthinkable: privatisation.
November 24, 2021

The three bidders for Unilabs compared

Two strategics and a private equity player are bidding for Unilabs, the Pan-European, Mid East and LaTam lab and imaging group. So who is likely to win?
November 23, 2021

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.
July 21, 2020

Asklepios set to win control of Rhoen

Asklepios has effectively taken over Rhoen Klinikum after B Braun with a 25% stake accepted the offer. The deal increases the consolidation in the private hospital sector.
June 18, 2020

COVID-19 and Emerging Market healthcare

We talk to two of the world's largest investors in emerging market health care about Covid's likely impact. Despite so far much lower death rates, the initial effect on health care operators has been worse than in Europe. Covid is set to destroy several motors for growth such as healthcare tourism and the deployment of […]
May 14, 2020

Health care service write-offs drive losses at Bupa

Bupa, the global healthcare insurer and healthcare operator went from pre-tax profits of £502m in 2018 to a loss of £78m in 2019, thanks mainly to huge write-offs in its UK dentistry business and Australian care homes. But stripping out write-offs, underlying profitability still plunged 31%. Revenue rose just 4%. Why, and what does this tell us about Bupa and its future?
March 11, 2020
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us